HB1724
Prescription Drug Affordability Board; established, drug cost affordability review, report.
Status:
Vetoed
Latest Action:
April 2, 2025
House: House sustained Governor's veto
Chief Patron:
Karrie Delaney (D)
Session:
2025 Regular Session
Summary
As Introduced. Prescription Drug Affordability Board established; drug cost affordability review.
Establishes the Prescription Drug Affordability Board for the purpose of protecting the citizens of the Commonwealth and other stakeholders within the health care system from the high costs of prescription drug products. The bill requires the Board to meet in open session at least four times annually, with certain exceptions ... (More) and requirements enumerated in the bill. Members of the Board are required to disclose any conflicts of interest, as described in the bill. The bill also creates a stakeholder council for the purpose of assisting the Board in making decisions related to drug cost affordability. The bill tasks the Board with identifying prescription, generic, and other drugs, as defined in the bill, that are offered for sale in the Commonwealth and, at the Board's discretion, conducting an affordability review of any prescription drug product. The bill lists factors for the Board to consider that indicate an affordability challenge for the health care system in the Commonwealth or high out-of-pocket costs for patients. The bill also provides that any person aggrieved by a decision of the Board may request an appeal of the Board's decision and that the Attorney General has authority to enforce the provisions of the bill. The bill provides that the Board shall establish no more than 12 upper payment limit amounts annually between January 1, 2026, and January 1, 2029. (Less)-
Bill History
- 01/04/2025 - House: Prefiled and ordered printed; Offered 01-08-2025 25100998D
- 01/04/2025 - House: Referred to Committee on Labor and Commerce
- 01/13/2025 - House: Placed on Labor and Commerce Agenda
- 01/14/2025 - House: Reported from Labor and Commerce and referred to Appropriations (12-Y 10-N)
- 01/14/2025 - House: Referred to Committee on Appropriations
- 01/15/2025 - House: Assigned Approps sub: Health & Human Resources
- 01/21/2025 - House: Fiscal Impact Statement from Department of Planning and Budget (HB1724)
- 01/23/2025 - House: Placed on Appropriations Agenda
- 01/24/2025 - House: Subcommittee recommends reporting (5-Y 2-N)
- 01/26/2025 - House: Placed on Appropriations Agenda
- 01/27/2025 - House: Reported from Appropriations (14-Y 8-N)
- 01/29/2025 - House: Read first time
- 01/30/2025 - House: Read second time and engrossed
- 01/31/2025 - House: Read third time and passed House (52-Y 44-N) Close Floor Vote
- 02/03/2025 - Senate: Constitutional reading dispensed (on 1st reading)
- 02/03/2025 - Senate: Referred to Committee on Commerce and Labor
- 02/10/2025 - Senate: Reported from Commerce and Labor and rereferred to Finance and Appropriations (10-Y 5-N)
- 02/10/2025 - Senate: Rereferred to Finance and Appropriations
- 02/14/2025 - Senate: Reported from Finance and Appropriations with substitute (10-Y 4-N)
- 02/14/2025 - Senate: Committee substitute printed 25107574D-S1
- 02/17/2025 - Senate: Rules suspended
- 02/17/2025 - Senate: Constitutional reading dispensed (on 2nd reading) (39-Y 0-N)
- 02/17/2025 - Senate: Passed by for the day
- 02/18/2025 - Senate: Read third time
- 02/18/2025 - Senate: Reading of substitute waived
- 02/18/2025 - Senate: Finance and Appropriations Substitute agreed to
- 02/18/2025 - Senate: Engrossed by Senate - committee substitute
- 02/18/2025 - Senate: Passed Senate with substitute (24-Y 16-N) Close Floor Vote
- 02/18/2025 - Senate: Reconsideration of Senate passage agreed to by Senate
- 02/18/2025 - Senate: Passed Senate with substitute (26-Y 14-N) Close Floor Vote
- 02/19/2025 - House: Senate substitute agreed to by House (52-Y 45-N) Close Floor Vote
- 02/19/2025 - House: Fiscal Impact Statement from Department of Planning and Budget (HB1724)
- 03/07/2025 - House: Enrolled
- 03/07/2025 - House: Bill text as passed House and Senate (HB1724ER)
- 03/07/2025 - House: Fiscal Impact Statement from Department of Planning and Budget (HB1724)
- 03/07/2025 - House: Signed by Speaker
- 03/10/2025 - Senate: Signed by President
- 03/11/2025 - House: Enrolled Bill communicated to Governor on March 11, 2024
- 03/11/2025 - Governor's Action Deadline 11:59 p.m., March 24, 2025
- 03/24/2025 - House: Governor's Veto Received by House
- 03/24/2025 - Vetoed by Governor
- 04/02/2025 - House: House sustained Governor's veto
